Lyndsey Young

Lyndsey Young is a seasoned professional in quality assurance with extensive experience in the biopharmaceutical sector. Currently serving as Senior Director of Quality at Tr1X since May 2023, Lyndsey has held key positions including Director of Quality Assurance at Maze Therapeutics, where oversight was provided for GMP, GLP, and GCP aspects of early clinical stage programs in cardiorenal, metabolic, and rare diseases. Previous roles include Director of Quality Assurance at Halozyme, Inc., leading commercial drug substance and product QA, and Associate Director of Quality Assurance at Nohla Therapeutics, overseeing an allogeneic cell therapy clinical program. Early career highlights include quality system management at Zymeworks Inc. and leadership roles in quality at Indi and Amgen. Lyndsey holds a Bachelor of Science in Chemistry from the University of Michigan.